NUR 502 Advance Patho Case Study

ST. Thomas University NUR 502 Advance Patho Case Study-Step-By-Step Guide

This guide will demonstrate how to complete the ST. Thomas University NUR 502 Advance Patho Case Study assignment based on general principles of academic writing. Here, we will show you the A, B, Cs of completing an academic paper, irrespective of the instructions. After guiding you through what to do, the guide will leave one or two sample essays at the end to highlight the various sections discussed below.

How to Research and Prepare for NUR 502 Advance Patho Case Study                         

Whether one passes or fails an academic assignment such as the ST. Thomas University NUR 502 Advance Patho Case Study depends on the preparation done beforehand. The first thing to do once you receive an assignment is to quickly skim through the requirements. Once that is done, start going through the instructions one by one to clearly understand what the instructor wants. The most important thing here is to understand the required format—whether it is APA, MLA, Chicago, etc.

After understanding the requirements of the paper, the next phase is to gather relevant materials. The first place to start the research process is the weekly resources. Go through the resources provided in the instructions to determine which ones fit the assignment. After reviewing the provided resources, use the university library to search for additional resources. After gathering sufficient and necessary resources, you are now ready to start drafting your paper.

How to Write the Introduction for NUR 502 Advance Patho Case Study                       

The introduction for the ST. Thomas University  NUR 502 Advance Patho Case Study is where you tell the instructor what your paper will encompass. In three to four statements, highlight the important points that will form the basis of your paper. Here, you can include statistics to show the importance of the topic you will be discussing. At the end of the introduction, write a clear purpose statement outlining what exactly will be contained in the paper. This statement will start with “The purpose of this paper…” and then proceed to outline the various sections of the instructions.

How to Write the Body for NUR 502 Advance Patho Case Study                       

After the introduction, move into the main part of the NUR 502 Advance Patho Case Study assignment, which is the body. Given that the paper you will be writing is not experimental, the way you organize the headings and subheadings of your paper is critically important. In some cases, you might have to use more subheadings to properly organize the assignment. The organization will depend on the rubric provided. Carefully examine the rubric, as it will contain all the detailed requirements of the assignment. Sometimes, the rubric will have information that the normal instructions lack.

Another important factor to consider at this point is how to do citations. In-text citations are fundamental as they support the arguments and points you make in the paper. At this point, the resources gathered at the beginning will come in handy. Integrating the ideas of the authors with your own will ensure that you produce a comprehensive paper. Also, follow the given citation format. In most cases, APA 7 is the preferred format for nursing assignments.

How to Write the Conclusion for NUR 502 Advance Patho Case Study                       

After completing the main sections, write the conclusion of your paper. The conclusion is a summary of the main points you made in your paper. However, you need to rewrite the points and not simply copy and paste them. By restating the points from each subheading, you will provide a nuanced overview of the assignment to the reader.

How to Format the References List for NUR 502 Advance Patho Case Study                         

The very last part of your paper involves listing the sources used in your paper. These sources should be listed in alphabetical order and double-spaced. Additionally, use a hanging indent for each source that appears in this list. Lastly, only the sources cited within the body of the paper should appear here.

Stuck? Let Us Help You

Completing assignments can sometimes be overwhelming, especially with the multitude of academic and personal responsibilities you may have. If you find yourself stuck or unsure at any point in the process, don’t hesitate to reach out for professional assistance. Our assignment writing services are designed to help you achieve your academic goals with ease. 

Our team of experienced writers is well-versed in academic writing and familiar with the specific requirements of the NUR 502 Advance Patho Case Study assignment. We can provide you with personalized support, ensuring your assignment is well-researched, properly formatted, and thoroughly edited. Get a feel of the quality we guarantee – ORDER NOW. 

NUR 502 Saint Thomas University Endocrine Function Case Study

Question Description

I’m working on a nursing case study and need an explanation to help me study.

Endocrine Function:

C.B. is a significantly overweight, 48-year-old woman from the Winnebago Indian tribe who had high blood sugar and cholesterol levels three years ago but did not follow up with a clinical diagnostic work-up. She had participated in the state’s annual health screening program and noticed that her fasting blood sugar was 141 and her cholesterol was 225. However, she felt “perfectly fine at the time” and could not afford any more medications. Except for a number of “female infections,” she has felt fine until recently. Today, she presents to the Indian Hospital general practitioner complaining that her left foot has been weak and numb for nearly three weeks and that the foot is difficult to flex. She denies any other weakness or numbness at this time. However, she reports that she has been very thirsty lately and gets up more often at night to urinate. She has attributed these symptoms to the extremely warm weather and drinking more water to keep hydrated. She has gained a total of 65 pounds since her last pregnancy 14 years ago, 15 pounds in the last 6 months alone.

Case Study Questions

1. In which race and ethnic groups is DM more prevalent? Based on C.B. clinical manifestations, please compile the signs and symptoms that she is exhibiting that are compatible with the Diabetes Mellitus Type 2 diagnosis.
2. If C.B. develop a bacterial pneumonia on her right lower lobe, how would you expect her Glycemia values to be? Explain and support your answer.
3. What would be the best initial therapy non-pharmacologic and pharmacologic to be recommended to C.B?

A Sample Answer For NUR 502 Advance Patho Case Study

Case Study

Potential most common sites for metastasis

The case study is of an 82-year-old man with a complaint of abdominal discomfort and a considerable loss of appetite as well as loss of weight, general weakness and frequent nausea. With a diagnosis of ductal adenocarcinoma, a variation of pancreatic cancer, the most common sites when it comes to metastasis would be the lining within the ducts of the pancreas, bones and lungs as well as the liver and lymph nodes (Anderson et al., 2021). These are considered to cover close to 60% of the reported cases of the condition.

What are tumor cell markers

Tumor cell markers are defined as being anything contained in or produced by cancer cells that can provide a descriptive function about the cancer type. This also extends to things produced by other cells within the body that do this as a general response to the presence of the cancerous cells and does not necessarily just have to be the cancer cells reacting (Sarantis et al., 2020). They are ordered for pancreatic patients because tumor cell markers can provide a lot of information concerning the cancer type. For instance, the tumor marker referred to as CA 19-9 and it helps to describe a pancreatic malignant situation.

TNM Stage classification

  Using the TNM Stage Classification, the patient in the case study has a cancer classification of T4N1M0 which is considered to be Stage III (Sarantis et al., 2020). There are a variety of reasons as to why classification is important. A simple one is that the staging allows the physician to know how aggressive the cancer is and what the suitable treatment module will be to start with. The treatments for cancer are numerous and choosing an appropriate one early on can go a long way to increasing chances of recovery. It also helps determine if the patient needs palliative care if the cancer is too aggressive at this point.

Characteristic of malignant tumors

            Malignant tumors are primarily characterized by having a rapid and uncontrolled growth cycle as well as an increased loss of differentiation, in addition to having poor boundaries as well as the capacity to tear away from the tumor site and move within the body (Anderson et al., 2021). This can be locally or within the blood stream of the patient. Their function becomes altered and they end up invading the surrounding cells as the metastasize and move within the circulatory system meaning if aggressive enough they can extend deep within the body. It can lead to multiple proliferation sites as the cancer spreads throughout.

Carcinogenesis Phase

            In the event a tumor metastasizes, the carcinogenic phase at this point will be found in the third stage. This point is referred to as the progression stage and it will see the tumor invade other cells as it moves away from its original site and then subsequently spreads (Principe et al., 2021). It will have increased resistance to pharmacological interventions and is deemed the last stage. It is irreversible.

Tissue Level

            With regards to the case in question, the tissue level that has been affected would be the epithelial tissue (Principe et al., 2021). The categorization of the tumor under adenocarcinoma is what shows that the epithelium is what is most affected.

References

 Anderson, E. M., Thomassian, S., Gong, J., Hendifar, A., & Osipov, A. (2021). Advances in pancreatic ductal adenocarcinoma treatment. Cancers, 13(21), 5510.

Principe, D. R., Underwood, P. W., Korc, M., Trevino, J. G., Munshi, H. G., & Rana, A. (2021). The current treatment paradigm for pancreatic ductal adenocarcinoma and barriers to therapeutic efficacy. Frontiers in Oncology, 11, 688377.

Sarantis, P., Koustas, E., Papadimitropoulou, A., Papavassiliou, A. G., & Karamouzis, M. V. (2020). Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy. World journal of gastrointestinal oncology, 12(2), 173.